NAFLD, alcohol-associated liver disease spurs rise in global liver cancer deaths

LONDON — Nonalcoholic fatty liver disease and alcohol-associated liver disease are among the main contributors of increased mortality related to chronic liver disease and liver cancer burden, according to research.“Although viral hepatitis B and C and alcohol liver disease have historically been the drivers of burden of chronic liver disease and liver cancer, NAFLD and nonalcoholic steatohepatitis have increasingly become more prominent,” Zobair Younossi, MD, MPH, president of Inova Health System Center for Liver Diseases, said. “The most recent meta-analysis suggestsRead More

Categories: News

Related Articles

Fatigue linked to worse clinical prognosis, quality of life in patients with NAFLD

LONDON — Lower fatigue scores at baseline correlated with adverse clinical events among patients with advanced nonalcoholic steatohepatitis, according to research presented at the International…

HIV an independent risk factor for nonalcoholic steatohepatitis

A study of more than 1,300 women demonstrated that HIV is an independent risk factor for nonalcoholic steatohepatitis with significant nonalcoholic fatty liver disease activity…

Fatigue in patients with advanced NASH may increase risk for adverse events

Worse fatigue at baseline among patients with nonalcohol steatohepatitis-related advanced fibrosis and cirrhosis correlated with a higher risk adverse clinical events, according to published results.“Although…

Nonalcoholic fatty liver disease linked to increased risk for dementia

Patients with nonalcoholic fatty liver disease had an increased risk for dementia, with stronger risk existing for those with comorbid heart disease or stroke, according…

Bulevirtide monotherapy safe, well-tolerated in chronic hepatitis D patients

LONDON — Bulevirtide induced a greater combined virologic and biochemical response compared with control at 48 weeks in patients with chronic hepatitis D infection, according…